These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19692477)

  • 1. Broad neutralization of human immunodeficiency virus type 1 mediated by plasma antibodies against the gp41 membrane proximal external region.
    Gray ES; Madiga MC; Moore PL; Mlisana K; Abdool Karim SS; Binley JM; Shaw GM; Mascola JR; Morris L
    J Virol; 2009 Nov; 83(21):11265-74. PubMed ID: 19692477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10.
    Nelson JD; Brunel FM; Jensen R; Crooks ET; Cardoso RM; Wang M; Hessell A; Wilson IA; Binley JM; Dawson PE; Burton DR; Zwick MB
    J Virol; 2007 Apr; 81(8):4033-43. PubMed ID: 17287272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1.
    Zwick MB; Jensen R; Church S; Wang M; Stiegler G; Kunert R; Katinger H; Burton DR
    J Virol; 2005 Jan; 79(2):1252-61. PubMed ID: 15613352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles.
    Phogat S; Svehla K; Tang M; Spadaccini A; Muller J; Mascola J; Berkower I; Wyatt R
    Virology; 2008 Mar; 373(1):72-84. PubMed ID: 18155743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing epitopes in the membrane-proximal external region of HIV-1 gp41 are influenced by the transmembrane domain and the plasma membrane.
    Montero M; Gulzar N; Klaric KA; Donald JE; Lepik C; Wu S; Tsai S; Julien JP; Hessell AJ; Wang S; Lu S; Burton DR; Pai EF; Degrado WF; Scott JK
    J Virol; 2012 Mar; 86(6):2930-41. PubMed ID: 22238313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged exposure of the HIV-1 gp41 membrane proximal region with L669S substitution.
    Shen X; Dennison SM; Liu P; Gao F; Jaeger F; Montefiori DC; Verkoczy L; Haynes BF; Alam SM; Tomaras GD
    Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5972-7. PubMed ID: 20231447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The broadly neutralizing anti-human immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5.
    Huarte N; Lorizate M; Maeso R; Kunert R; Arranz R; Valpuesta JM; Nieva JL
    J Virol; 2008 Sep; 82(18):8986-96. PubMed ID: 18596094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency.
    Jacob RA; Moyo T; Schomaker M; Abrahams F; Grau Pujol B; Dorfman JR
    J Virol; 2015 May; 89(10):5264-75. PubMed ID: 25673728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal residues of an HIV-1 gp41 membrane-proximal external region antigen influence broadly neutralizing 2F5-like antibodies.
    Li D; Liu J; Zhang L; Xu T; Chen J; Wang L; Zhao Q
    Virol Sin; 2015 Dec; 30(6):449-56. PubMed ID: 26715302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection and immune recognition of HIV-1 MPER mimotopes.
    Wieczorek L; Peachman K; Steers N; Schoen J; Rao M; Polonis V; Rao V
    Virology; 2020 Nov; 550():99-108. PubMed ID: 32980676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment.
    Luo M; Yuan F; Liu Y; Jiang S; Song X; Jiang P; Yin X; Ding M; Deng H
    Vaccine; 2006 Jan; 24(4):435-42. PubMed ID: 16143433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadth.
    Shen X; Parks RJ; Montefiori DC; Kirchherr JL; Keele BF; Decker JM; Blattner WA; Gao F; Weinhold KJ; Hicks CB; Greenberg ML; Hahn BH; Shaw GM; Haynes BF; Tomaras GD
    J Virol; 2009 Apr; 83(8):3617-25. PubMed ID: 19193787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C.
    Binley JM; Lybarger EA; Crooks ET; Seaman MS; Gray E; Davis KL; Decker JM; Wycuff D; Harris L; Hawkins N; Wood B; Nathe C; Richman D; Tomaras GD; Bibollet-Ruche F; Robinson JE; Morris L; Shaw GM; Montefiori DC; Mascola JR
    J Virol; 2008 Dec; 82(23):11651-68. PubMed ID: 18815292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of immunoglobulin G Fc receptors by human immunodeficiency virus type 1: a specific role for antibodies against the membrane-proximal external region of gp41.
    Perez LG; Costa MR; Todd CA; Haynes BF; Montefiori DC
    J Virol; 2009 Aug; 83(15):7397-410. PubMed ID: 19458010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-guided alterations of the gp41-directed HIV-1 broadly neutralizing antibody 2F5 reveal new properties regarding its neutralizing function.
    Guenaga J; Wyatt RT
    PLoS Pathog; 2012; 8(7):e1002806. PubMed ID: 22829767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membrane-proximal external region-neutralizing antibody response.
    Gray ES; Moore PL; Bibollet-Ruche F; Li H; Decker JM; Meyers T; Shaw GM; Morris L
    J Virol; 2008 Mar; 82(5):2367-75. PubMed ID: 18094155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable docking of neutralizing human immunodeficiency virus type 1 gp41 membrane-proximal external region monoclonal antibodies 2F5 and 4E10 is dependent on the membrane immersion depth of their epitope regions.
    Dennison SM; Stewart SM; Stempel KC; Liao HX; Haynes BF; Alam SM
    J Virol; 2009 Oct; 83(19):10211-23. PubMed ID: 19640992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of HIV-1 neutralization by antibodies targeting a membrane-proximal region of gp41.
    Chen J; Frey G; Peng H; Rits-Volloch S; Garrity J; Seaman MS; Chen B
    J Virol; 2014 Jan; 88(2):1249-58. PubMed ID: 24227838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting antibody responses to the membrane proximal external region of the envelope glycoprotein of human immunodeficiency virus.
    Kamdem Toukam D; Tenbusch M; Stang A; Temchura V; Storcksdieck Genannt Bonsmann M; Grewe B; Koch S; Meyerhans A; Nchinda G; Kaptue L; Uberla K
    PLoS One; 2012; 7(5):e38068. PubMed ID: 22666448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity.
    Bradley T; Trama A; Tumba N; Gray E; Lu X; Madani N; Jahanbakhsh F; Eaton A; Xia SM; Parks R; Lloyd KE; Sutherland LL; Scearce RM; Bowman CM; Barnett S; Abdool-Karim SS; Boyd SD; Melillo B; Smith AB; Sodroski J; Kepler TB; Alam SM; Gao F; Bonsignori M; Liao HX; Moody MA; Montefiori D; Santra S; Morris L; Haynes BF
    EBioMedicine; 2016 Oct; 12():196-207. PubMed ID: 27612593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.